Richard Whitlock (surgeon)

Last updated
Richard Whitlock
Education McMaster University (BSc, MSc, PhD)
University of Toronto (MD)
Occupation(s) Cardiovascular surgeon and Intensivist
Medical career
Institutions McMaster University
Population Health Research Institute
Research

Richard Whitlock FRCSC is a Canadian cardiovascular surgeon and intensivist, the Canada Research Chair in Cardiovascular Surgery and a professor of surgery at McMaster University Medical School. He is most well known for being the principal investigator of the SIRS (Steroids in Cardiac Surgery) trial and the LAAOS III (Left Atrial Appendage Occlusion Study) trial. [1] On April 9, 2015, Whitlock and his team performed the first transcatheter aortic valve implantation on a pregnant woman in the world. [2]

Contents

Education

Whitlock completed his B.Sc. in biochemistry at McMaster University in 1997 and his M.D. at the University of Toronto, graduating in 2001.[ citation needed ] He completed his residency in cardiac surgery at McMaster University Medical School in 2007 and followed up by completing a critical care fellowship in 2008 at the same institution. During residency, he completed his M.Sc. in health research methodology at McMaster University in 2004. He subsequently completed his Ph.D. in cardiac surgery at McMaster University in 2012. [3]

Career

Whitlock joined the Department of Cardiac Surgery at McMaster University as an assistant professor and staff cardiac surgeon and staff intensivist in 2008. He also became a P.I. at the Population Health Research Institute at the same time. In 2012, he was promoted to associate professor and in 2019, he was promoted to professor of surgery at McMaster University.

Research

In 2012, Whitlock authored the 2012 American College of Chest Physicians guideline on antithrombotic and thrombolytic therapy for valvular disease.[ citation needed ] In 2015, Whitlock published the SIRS trial, the largest cardiovascular surgery trial in the world to date, which showed no benefit of corticosteroids in on-pump cardiac surgery. [1] In 2021, Whitlock published the LAAOS III trial, a trial which showed left atrial appendage occlusion, a simple additional procedure during cardiac surgery, reduced stroke rates significantly in patients with baseline atrial fibrillation. [4]

Awards

Related Research Articles

<span class="mw-page-title-main">Cardiothoracic surgery</span> Medical specialty involved in surgical treatment of organs inside the thorax

Cardiothoracic surgery is the field of medicine involved in surgical treatment of organs inside the thoracic cavity — generally treatment of conditions of the heart, lungs, and other pleural or mediastinal structures.

<span class="mw-page-title-main">Cardiac surgery</span> Type of surgery performed on the heart

Cardiac surgery, or cardiovascular surgery, is surgery on the heart or great vessels performed by cardiac surgeons. It is often used to treat complications of ischemic heart disease ; to correct congenital heart disease; or to treat valvular heart disease from various causes, including endocarditis, rheumatic heart disease, and atherosclerosis. It also includes heart transplantation.

<span class="mw-page-title-main">University of Ottawa Heart Institute</span> Hospital in Ottawa, Ontario

The University of Ottawa Heart Institute (UOHI) (French: Institut de cardiologie de l'Université d'Ottawa ) is Canada's largest cardiovascular health centre. It is located in Ottawa, Ontario, Canada. It began as a department in The Ottawa Hospital, and since has evolved into Canada's only complete cardiac centre, encompassing prevention, diagnosis, treatment, rehabilitation, research, and education.

<span class="mw-page-title-main">Atrium (heart)</span> Part of the human heart

The atrium is one of the two upper chambers in the heart that receives blood from the circulatory system. The blood in the atria is pumped into the heart ventricles through the atrioventricular mitral and tricuspid heart valves.

David H. Adams is an American cardiac surgeon and the Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery, Icahn School of Medicine at Mount Sinai Hospital in New York City. Dr. Adams is a recognized leader in the field of heart valve surgery and mitral valve reconstruction. As director of Mount Sinai Mitral Valve Repair Center, he has set national benchmarks with >99% degenerative mitral valve repair rates, while running one of the largest valve repair programs in the United States. Dr. Adams is the co-inventor of 2 mitral valve annuloplasty repair rings – the Carpentier-McCarthy-Adams IMR ETlogix Ring and the Carpentier-Edwards Physio II Annuloplasty Ring, and is a senior consultant with royalty agreements with Edwards Lifesciences. He is also the inventor of the Tri-Ad Adams Tricuspid Annuloplasty ring with a royalty agreement with Medtronic. He is a co-author with Professor Alain Carpentier of the benchmark textbook in mitral valve surgery Carpentier's Reconstructive Valve Surgery. He is also the National Co-Principal Investigator of the FDA pivotal trial of the Medtronic-CoreValve transcatheter aortic valve replacement device.

<span class="mw-page-title-main">Robert E. Michler</span>

Robert E. Michler is an American heart surgeon specializing in heart surgery, aortic and mitral valve repair, coronary artery bypass surgery, aneurysm surgery, and management of the failing heart. In 2017, Michler received the Vladimir Borakovsky Prize in Moscow from the Ministry of Health of the Russian Federation for “his personal contributions to the development of cardiovascular surgery”.

<span class="mw-page-title-main">Left atrial appendage occlusion</span> Medical treatment

Left atrial appendage occlusion (LAAO), also referred to as left atrial appendage closure (LAAC), is a procedure used to reduce the risk of blood clots from the left atrial appendage entering the bloodstream and causing a stroke in those with non-valvular atrial fibrillation.

The management of atrial fibrillation (AF) is focused on preventing temporary circulatory instability, stroke and other ischemic events. Control of heart rate and rhythm are principally used to achieve the former, while anticoagulation may be employed to decrease the risk of stroke. Within the context of stroke, the discipline may be referred to as stroke prevention in atrial fibrillation (SPAF). In emergencies, when circulatory collapse is imminent due to uncontrolled rapid heart rate, immediate cardioversion may be indicated.

Jonathan L. Halperin is an American cardiologist and the author of Bypass (ISBN 0-89586-509-2), among the most comprehensive works on the subject of coronary artery bypass surgery. In addition, he is the Robert and Harriet Heilbrunn Professor of Medicine at The Mount Sinai School of Medicine as well as Director of Clinical Cardiology in the Zena and Michael A. Wierner Cardiovascular Institute at The Mount Sinai Medical Center, both in New York City. Halperin was the principal cardiologist responsible for both the design and execution of the multi-center Stroke Prevention in Atrial Fibrillation (SPAF) clinical trials, funded by the National Institutes of Health, which helped develop antithrombotic strategies to prevent stroke, and he subsequently directed the SPORTIF clinical trials, which evaluated the first oral direct thrombin inhibitor for prevention of stroke in patients with atrial fibrillation.

Lars Georg Svensson is a cardiac surgeon and the chairman of the heart and vascular institute at Cleveland Clinic. He is the Director of the Aorta Center, Director of the Marfan Syndrome and Connective Tissue Disorder Clinic, and is a professor of surgery at Cleveland Clinic Lerner College of Medicine and Case Western Reserve University. He is also the Director of Quality Outcomes and Process Improvement for the Department of Thoracic and Cardiovascular Surgery and Affiliate Cardiac Surgery Program at Cleveland Clinic.

James L. Cox is an American cardiothoracic surgeon and medical innovator best known for the development of the Cox maze procedure for treatment of atrial fibrillation in 1987.

A. Marc Gillinov is an American cardiac surgeon at The Cleveland Clinic, where he is Chair of the Department of Thoracic and Cardiovascular Surgery.

Randall K. Wolf, MD, FACS, FACC is a cardiothoracic surgeon, inventor, former radio personality, and magician. He is the creator of the Wolf Mini Maze, a procedure used to correct atrial fibrillation (AF). Wolf previously hosted a weekly radio show, "Take Charge of Your Health" on WKRC (AM) in Cincinnati, Ohio from 2011-2014.

Richard Lee is a cardiac surgeon in St. Louis, Missouri, who helped pioneer a staged Hybrid Maze, a procedure for atrial fibrillation or AFIB. combining surgery and catheter based approaches.

Michael J. Reardon is an American cardiac surgeon and medical researcher. He is known for his work in heart autotransplantation for malignant heart tumors, an operation in which the surgeon removes the patient's heart, cuts out the malignant tumor, and reimplants the heart back in the patient's chest. He performed the first successful heart autotransplantation for a cancerous heart tumor in 1998.

Ulf Landmesser is a German specialist for cardiology and internal medicine. He is professor at the Institute for Health Research in Berlin and Head of the Medical Clinic of Cardiology at the Charité in Berlin. Landmesser is known for his work on coronary interventions and modern methods of catheter-based heart valve therapy.

Richard D. Weisel, is a Canadian-American cardiovascular surgeon and a professor of surgery at University of Toronto. He is the current editor-in-chief of the Journal of Thoracic and Cardiovascular Surgery and the current director of the Cardiothoracic Surgical Trials Network. He is known for demonstrating that volume loading during cardiac surgery improved stroke volume in patients post-operatively. He is also a researcher specializing in myocardial protection, cardiac regeneration and stem cells.

Philip James Devereaux is a Canadian cardiologist, clinical epidemiologist, and perioperative care physician. Devereaux conducts clinical research within cardiac and perioperative fields, with a focus on vascular surgical complications.

John D. Puskas is an American researcher, author, inventor and cardiovascular surgeon. As of 2022, he is Professor, Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, and chairman, Department of Cardiovascular Surgery at Mount Sinai Morningside, Mount Sinai Beth Israel and Mount Sinai West. He holds 11 U.S. patents and co-founded the International Coronary Congress and the International Society for Coronary Artery Surgery. He is credited by ResearchGate with 330 publications and 15,234 citations and as of 2022 Scopus reports an h-index of 62. Puskas is known for advancing coronary artery bypass (CABG) surgery by refining surgical techniques for all-arterial, off-pump CABG and inventing finer instruments to be used for advanced coronary bypass surgical procedures. He is credited with performing the first totally thoracoscopic bilateral pulmonary vein isolation procedure. He is the co-editor of State of the Art Surgical Coronary Revascularization, the first textbook solely devoted to coronary artery surgery.

Mario F.L. Gaudino, MD, PhD, MSCE, FEBCTS, FACC, FAHA is an Italian cardiothoracic surgeon who is the Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery (II) and Professor of Clinical Epidemiology and Health Services Research at Weill Cornell Medicine and an attending cardiac surgeon at NewYork-Presbyterian Hospital and Weill Cornell Medical Center. He is an expert in coronary revascularization and clinical trialist. He is known for conducting the PALACS trial, which demonstrated that posterior pericardiotomy at the time of cardiac surgery reduced the incidence of post-operative atrial fibrillation and pericardial effusion.

References

  1. 1 2 3 4 "Dr. Richard Whitlock". PHRI. PHRI. Retrieved 10 March 2016.
  2. ↑ "Making History at Hamilton General Hospital with Surgery on Pregnant Woman". HHS. HHS. Retrieved 10 March 2016.
  3. ↑ "Richard Whitlock". CPSO. CPSO. Retrieved 10 March 2016.
  4. ↑ Whitlock, Richard (2021). "Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke". New England Journal of Medicine. 384 (22). NEJM: 2081–2091. doi:10.1056/NEJMoa2101897. hdl: 10044/1/89235 . PMID   33999547. S2CID   234747730 . Retrieved 6 October 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.